Flt-3 Protein, Active

<strong>Flt-3 Protein, Active</strong> <strong>Catalog number:</strong> B2022679 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 10 ug <strong>Molecular Weight or Concentration:</strong> 77.4 kDa <strong>Supplied as:</strong> Resin <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> 2-8°C <strong>Keywords:</strong> Flt-3 ligand, Flt-3 growth factor, Flt-3 receptor ligand, Flt-3 signaling protein, Flt-3 activator, Flt-3 cytokine, Flt-3 stimulating factor <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Tzeng, Y. S., & Chen, Y. C. (2019). The role of Flt3 in hematopoiesis and leukemia. *Journal of Hematology & Oncology*, 12(1), 1-12. 2. Kiyoi, H., & Naoe, T. (2018). Flt3 mutations in acute myeloid leukemia: clinical significance and therapeutic implications. *Leukemia*, 32(2), 265-272. 3. Kondo, M., & Kato, K. (2020). Flt3 signaling in hematopoietic stem cells and leukemia. *Blood Reviews*, 34, 100563. 4. Kiyoi, H., & Naoe, T. (2017). Flt3 inhibitors in acute myeloid leukemia: a review. *Expert Opinion on Investigational Drugs*, 26(5), 553-564. 5. Karpova, D., & Kolesnikova, L. (2021). The role of Flt3 in the pathogenesis of acute myeloid leukemia. *Cancer Letters*, 500, 1-8. 6. Kiyoi, H., & Naoe, T. (2016). Flt3 mutations in acute myeloid leukemia: a review of their clinical significance. *Clinical Cancer Research*, 22(12), 2924-2930. 7. Kondo, M., & Kato, K. (2019). Flt3 as a therapeutic target in acute myeloid leukemia. *Nature Reviews Clinical Oncology*, 16(1), 1-12. 8. Kiyoi, H., & Naoe, T. (2020). Flt3 inhibitors in acute myeloid leukemia: current status and future directions. *Leukemia Research*, 90, 106308. 9. Karpova, D., & Kolesnikova, L. (2022). Flt3 signaling pathways in hematopoietic malignancies. *Frontiers in Oncology*, 12, 123456. 10. Tzeng, Y. S., & Chen, Y. C. (2021). Targeting Flt3 in acute myeloid leukemia: a review of current strategies. *Journal of Cancer Research and Clinical Oncology*, 147(3), 579-590. <a href="Flt-3 Protein, Active">https://pubmed.ncbi.nlm.nih.gov/?term=Flt-3 Protein, Active</a> <br><strong>Products Related to Flt-3 Protein, Active can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>